Literature DB >> 27634200

Necroptosis in spontaneously-mutated hematopoietic cells induces autoimmune bone marrow failure in mice.

Junping Xin1,2,3, Peter Breslin4,5,6, Wei Wei4, Jing Li7, Rafael Gutierrez4, Joseph Cannova4, Allen Ni4, Grace Ng4, Rachel Schmidt4, Haiyan Chen8, Vamsi Parini8, Paul C Kuo4, Ameet R Kini8, Patrick Stiff4, Jiang Zhu9, Jiwang Zhang1,8.   

Abstract

Acquired aplastic anemia is an autoimmune-mediated bone marrow failure syndrome. The mechanism by which such an autoimmune reaction is initiated is unknown. Whether and how the genetic lesions detected in patients cause autoimmune bone marrow failure have not yet been determined. We found that mice with spontaneous deletion of the TGFβ-activated kinase-1 gene in a small subset of hematopoietic cells developed bone marrow failure which resembled the clinical manifestations of acquired aplastic anemia patients. Bone marrow failure in such mice could be reversed by depletion of CD4+ T lymphocytes or blocked by knockout of interferon-γ, suggesting a Th1-cell-mediated autoimmune mechanism. The onset and progression of bone marrow failure in such mice were significantly accelerated by the inactivation of tumor necrosis factor-α signaling. Tumor necrosis factor-α restricts autoimmune bone marrow failure by inhibiting type-1 T-cell responses and maintaining the function of myeloid-derived suppressor cells. Furthermore, we determined that necroptosis among a small subset of mutant hematopoietic cells is the cause of autoimmune bone marrow failure because such bone marrow failure can be prevented by deletion of receptor interacting protein kinase-3 Our study suggests a novel mechanism to explain the pathogenesis of autoimmune bone marrow failure. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27634200      PMCID: PMC5286937          DOI: 10.3324/haematol.2016.151514

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  56 in total

1.  Functional characterization of CD4+ T cells in aplastic anemia.

Authors:  Shahram Kordasti; Judith Marsh; Sufyan Al-Khan; Jie Jiang; Alexander Smith; Azim Mohamedali; Pilar Perez Abellan; Caroline Veen; Benedetta Costantini; Austin G Kulasekararaj; Nana Benson-Quarm; Thomas Seidl; Syed A Mian; Farzin Farzaneh; Ghulam J Mufti
Journal:  Blood       Date:  2011-12-02       Impact factor: 22.113

Review 2.  Necroptosis: the release of damage-associated molecular patterns and its physiological relevance.

Authors:  Agnieszka Kaczmarek; Peter Vandenabeele; Dmitri V Krysko
Journal:  Immunity       Date:  2013-02-21       Impact factor: 31.745

Review 3.  Aplastic anaemia.

Authors:  Robert A Brodsky; Richard J Jones
Journal:  Lancet       Date:  2005 May 7-13       Impact factor: 79.321

4.  Immune-mediated bone marrow failure in C57BL/6 mice.

Authors:  Jichun Chen; Marie J Desierto; Xingmin Feng; Angélique Biancotto; Neal S Young
Journal:  Exp Hematol       Date:  2014-12-30       Impact factor: 3.084

Review 5.  Necroptosis and its role in inflammation.

Authors:  Manolis Pasparakis; Peter Vandenabeele
Journal:  Nature       Date:  2015-01-15       Impact factor: 49.962

Review 6.  Pathophysiologic mechanisms in acquired aplastic anemia.

Authors:  Neal S Young
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

7.  RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3.

Authors:  Christopher P Dillon; Ricardo Weinlich; Diego A Rodriguez; James G Cripps; Giovanni Quarato; Prajwal Gurung; Katherine C Verbist; Taylor L Brewer; Fabien Llambi; Yi-Nan Gong; Laura J Janke; Michelle A Kelliher; Thirumala-Devi Kanneganti; Douglas R Green
Journal:  Cell       Date:  2014-05-08       Impact factor: 41.582

Review 8.  Clonality of the stem cell compartment during evolution of myelodysplastic syndromes and other bone marrow failure syndromes.

Authors:  R Tiu; L Gondek; C O'Keefe; J P Maciejewski
Journal:  Leukemia       Date:  2007-06-07       Impact factor: 11.528

9.  Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4.

Authors:  Kim Newton; Xiaoqing Sun; Vishva M Dixit
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

10.  Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis.

Authors:  Justine E Roderick; Nicole Hermance; Matija Zelic; Matthew J Simmons; Apostolos Polykratis; Manolis Pasparakis; Michelle A Kelliher
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

View more
  6 in total

Review 1.  The bone-marrow niche in MDS and MGUS: implications for AML and MM.

Authors:  Irene M Ghobrial; Alexandre Detappe; Kenneth C Anderson; David P Steensma
Journal:  Nat Rev Clin Oncol       Date:  2018-01-09       Impact factor: 66.675

Review 2.  RIPK3 signaling and its role in the pathogenesis of cancers.

Authors:  Shanhui Liu; Kanak Joshi; Mitchell F Denning; Jiwang Zhang
Journal:  Cell Mol Life Sci       Date:  2021-10-15       Impact factor: 9.207

3.  Ripk3 signaling regulates HSCs during stress and represses radiation-induced leukemia in mice.

Authors:  Lei Zhang; Huacheng Luo; Hong-Min Ni; Shanhui Liu; Hongyun Xing; Jun Zhang; Mark Sellin; Peter Breslin S J; Wei Wei; Mitchell F Denning; William Small; Wen-Xing Ding; Suming Huang; Jiwang Zhang
Journal:  Stem Cell Reports       Date:  2022-05-12       Impact factor: 7.294

4.  Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations.

Authors:  Stanley Chun-Wei Lee; Khrystyna North; Eunhee Kim; Eunjung Jang; Esther Obeng; Sydney X Lu; Bo Liu; Daichi Inoue; Akihide Yoshimi; Michelle Ki; Mirae Yeo; Xiao Jing Zhang; Min Kyung Kim; Hana Cho; Young Rock Chung; Justin Taylor; Benjamin H Durham; Young Joon Kim; Alessandro Pastore; Sebastien Monette; James Palacino; Michael Seiler; Silvia Buonamici; Peter G Smith; Benjamin L Ebert; Robert K Bradley; Omar Abdel-Wahab
Journal:  Cancer Cell       Date:  2018-08-13       Impact factor: 31.743

Review 5.  Myeloid-Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets.

Authors:  Nikoleta Bizymi; Sunčica Bjelica; Astrid Olsnes Kittang; Slavko Mojsilovic; Maria Velegraki; Charalampos Pontikoglou; Mikael Roussel; Elisabeth Ersvær; Juan Francisco Santibañez; Marie Lipoldová; Helen A Papadaki
Journal:  Hemasphere       Date:  2019-01-28

Review 6.  Necroinflammation emerges as a key regulator of hematopoiesis in health and disease.

Authors:  Philipp J Jost; Ulrike Höckendorf
Journal:  Cell Death Differ       Date:  2018-09-21       Impact factor: 15.828

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.